BioSpace News Archive

Drug Development

Zogenix Announces Initiation of Phase III Trial for ZX008 in Lennox-Gastaut Syndrome

The Phase 3 multicenter, global LGS trial is divided in two parts.

November 29, 2017
·
5 min read
Deals

scPharmaceuticals Announces Closing of Over-Allotment Option in its Initial Public Offering

scPharmaceuticals common shares began trading on The Nasdaq Global Select Market under the ticker symbol “SCPH” on November 17, 2017.

November 29, 2017
·
2 min read
Pharm Country

PhaseBio Announces $15.6M in Funds to Support Clinical Advancement of Orphan Cardiovascular Pipeline

PhaseBio entered into a $7.5 million term loan facility with Silicon Valley Bank, subject to funding in up to three tranches.

November 29, 2017
·
2 min read
Drug Development

Rebiotix Announces Expansion of Phase I Trial of the Company’s Oral Capsule Microbiota Product, RBX7455, Following Successful Completion of Initial Study Arms

The expansion follows the successful completion of the study’s two initial cohorts and is intended to explore reduced dosing regimens of RBX7455 in two new treatment arms.

November 29, 2017
·
4 min read
Genetown

CardioFocus Completes Successful Controlled U.S. Commercial Launch of the HeartLight System

CardioFocus today announced the successful completion of its controlled U.S. commercial launch of the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation.

November 29, 2017
·
3 min read
Business

Mitra Biotech Partners With Gotect Diagnostic in Israel

Mitra Biotech today announced an agreement with Gotect Diagnostic for the exclusive right to represent Mitra in Israel.

November 29, 2017
·
2 min read
Genetown

Fresenius Medical Care North America Sets Record in Surpassing its Kidney Walk Fundraising Goal

FMCNA raises largest amount ever by a National Team during the 2017 Kidney Walks for the National Kidney Foundation.

November 29, 2017
·
3 min read